Monitor upcoming clinical data from the ELIMINATE-B (HBV) and FUNCTION-DMD (Duchenne) studies; the leadership restructuring signals a focus on operational execution and pipeline advancement, but no near-term catalyst is provided.
Price Chart
Executive Summary
Precision BioSciences announced a senior leadership reshuffle effective August 1, 2026: CFO Alex Kelly promoted to the newly created COO role, VP of IR Naresh Tanna promoted to CFO, and Mei Burris designated as principal accounting officer. The changes are internal promotions aimed at supporting the advance of lead gene-editing programs PBGENE-HBV and PBGENE-DMD, with no financial data or guidance provided.
Key Facts
- Alex Kelly promoted from CFO to COO (new role), salary increased to $510,000 with 45% bonus target
- Naresh Tanna promoted to CFO, salary $400,000 with 40% bonus target; previously VP of IR and Chief of Staff
- Mei Burris designated as principal accounting officer and Chief Accounting Officer, no compensation change
- Two new physician leaders hired under Chief Development Officer Cindy Atwell for infectious disease and muscular dystrophy expertise
- Leadership changes support clinical programs PBGENE-HBV (chronic hepatitis B) and PBGENE-DMD (Duchenne muscular dystrophy)
Financial Impact
No financial data disclosed; executive salary adjustments are routine and immaterial relative to company size
Risk Factors
- No risk identified from this filing; it is a routine organizational update
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-049665 |
| Document: precisionleadershipchanges.htm | 0001628280-26-049665 |
| Document: 0001628280-26-049665-index-headers.html | 0001628280-26-049665 |
| Document: 0001628280-26-049665-index.html | 0001628280-26-049665 |
| Document: 0001628280-26-049665.txt | 0001628280-26-049665 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 4w ago | Institutional Cluster | $7.19 $6.36 | ▼ −11.54% | ▼ −10.82% | $6.41 (−10.85%) |
Aug 24, 2026 9w ago | 8-K | $8.45 $8.55 | ▲ +1.18% | ▲ +0.86% | $6.41 (−24.14%) |
Aug 6, 2026 11w ago | 8-K | $7.42 $7.49 | ▲ +0.94% | ▲ +0.33% | $6.41 (−13.61%) |
Jul 27, 2026 13w ago | 8-K | $7.25 $7.17 | ▼ −1.10% | ▼ −1.34% | $6.41 (−11.59%) |
Jul 1, 2026 16w ago | 8-K | $7.88 $8.18 | ▲ +3.81% | ▲ +3.94% | $6.41 (−18.65%) |
Jun 16, 2026 18w ago | 8-K | $6.50 $6.81 | ▲ +4.77% | ▲ +3.99% | $6.41 (−1.38%) |
May 27, 2026 21w ago | 8-K | $7.59 $6.92 | ▼ −8.83% | ▼ −9.38% | $6.41 (−15.55%) |
May 26, 2026 21w ago | 8-K | $7.59 $6.92 | ▼ −8.83% | ▼ −9.38% | $6.41 (−15.55%) |
May 5, 2026 24w ago | 8-K | $7.45 $7.52 | ▲ +0.94% | ▼ −0.45% | $6.41 (−13.96%) |
Apr 8, 2026 28w ago | DEFA14A | $5.99 $6.61 | ▲ +10.35% | ▲ +9.78% | $6.41 (+7.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers